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Background: Expression of the IL-7R gene is up-/down-regulated during T/B-lymphocyte development.
Results: IL-7R gene transcription is repressed by the transcription factor Gfi1, specifically in CD8 T-lymphocytes.
Conclusion: Treatment by dexamethasone down-regulates Gfi1, which contributes to glucocorticoid receptor mediated up-
regulation of IL-7R expression.
Significance: The mechanism by which the IL-7R gene gets turned on and off during development is a critical issue in biology.
Interleukin-7 receptor  (IL-7R) is essential for T cell sur-
vival and differentiation. Glucocorticoids are potent enhancers
of IL-7R expression with diverse roles in T cell biology. Here
we identify the transcriptional repressor, growth factor inde-
pendent-1 (Gfi1), as a novel intermediary in glucocorticoid-in-
duced IL-7Rup-regulation.We foundGfi1 to be amajor inhib-
itory target of dexamethasone by microarray expression
profiling of 3B4.15 T-hybridoma cells. Concordantly, retroviral
transduction ofGfi1 significantly blunted IL-7R up-regulation
by dexamethasone. To further assess the role of Gfi1 in vivo, we
generated bacterial artificial chromosome (BAC) transgenic
mice, inwhich amodified Il7r locus expressesGFP to report Il7r
gene transcription. By introducing this BAC reporter transgene
into eitherGfi1-deficient orGfi1-transgenicmice, we document
in vivo that IL-7R transcription is up-regulated in the absence
of Gfi1 and down-regulated when Gfi1 is overexpressed. Strik-
ingly, the in vivo regulatory role of Gfi1 was specific for CD8,
and not CD4 T cells or immature thymocytes. These results
identify Gfi1 as a specific transcriptional repressor of the Il7r
gene in CD8 T lymphocytes in vivo.
A critical issue in biology is the mechanism by which genes
get turned on and off during development and differentiation.
Because IL-7 receptor (IL-7R) proteins provide critical survival
signals to developing lymphocytes, the expression of the Il7r
gene that encodes the IL-7R receptor protein is tightly regu-
lated at different stages of T and B lymphocyte development
and precisely timed to stages when selection and programmed
cell death occur in the immune system (1–3). The expression of
IL-7R follows an on-off-on pattern in the thymus at the
CD4CD8 double negative (DN),8 CD4CD8 double posi-
tive (DP), and CD4CD8 or CD4CD8 single positive (SP)
stages, respectively (4). Thus, developmental cues during thy-
mocyte differentiation control IL-7R expression. During
CD8 memory cell generation in the peripheral immune sys-
tem, Il7r gene expression again correlates with developmental
outcome, in that long-livedmemory cell precursors up-regulate
IL-7R expression and short-lived CD8 cells lose IL-7R
expression (5). Notably, up-regulated IL-7R expression is not
sufficient to drive long-lived memory CD8 T cell generation,
even though IL-7R up-regulation clearlymarks progenitors of
this T cell subset (6, 7). Importantly, the differentiation signals
that match IL-7R expression to CD8 T cell fate remain
unknown.
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In T cells, IL-7R expression is thought to be primarily reg-
ulated at the transcriptional level through an array of nuclear
factors whose expression is also tightly controlled during devel-
opment and activation. Several transcription factors that con-
trol Il7r gene expression have been identified. The promoter of
Il7r contains binding sites for the PU.1 transcription factor,
which is necessary for the IL-7R expression in developing B
cells (8, 9). The same site is occupied in T cells by another ETS
family transcription factor, GABP (10). Promoter occupancy by
these factors likely prevents CpG methylation of promoter
sequences and subsequent down-regulation of expression in
mature T cells (11). Additionally, in human thymopoiesis,
Notch may be complementing these ETS family proteins by
acting through a conserved RBP-Jk/CSL binding site close by in
the promoter of the Il7r gene (12). Therefore, down-regulation
of Notch expression at the DP stage may be causative of the
complete loss of Il7r gene transcription in murine DP thymo-
cytes. Also, the potential role of microRNAs acting on the Il7r
gene locus, specifically at the DP stage has not been addressed
and needs to be tested. Furthermore, the zinc finger protein
Gfi1, for which a regulatory role was originally proposed in T
cells and more recently confirmed in pro-B cells, was shown to
bind to a putative intronic silencer (13–15). Additionally, glu-
cocorticoid receptor (GR), Runx1/3, FoxOA1/3, and FoxP1
were all shown to bind to a putative enhancer in an evolution-
arily conserved region 3.5 kb upstream of the gene (16–21).
Finally FoxP3 was found to bind near the promoter in Treg cells
to suppress IL-7R transcription (22). Importantly, however,
how these factors interact with each other and what controls
the mechanism of developmental stage-specific differences in
Il7r gene transcription remains ill defined.
In the present study, we addressed this issue first by profiling
gene expression in 3B4.15 T hybridoma cells that respond to
dexamethasone (Dex) treatment by up-regulating IL-7R
expression (23). We identified Gfi1 as a novel target of Dex and
we further documented that either Gfi1 overexpression or
treatment with the glucocorticoid receptor (GR) inhibitor
RU486 (Mifepristone) in 3B4.15 cells prevented IL-7R up-reg-
ulation by Dex. These results indicate that Gfi1 is either con-
trolled by GR or cooperates with it to down-regulate IL-7R
expression. To further assess the role of Gfi1 in vivo, we then
generated a novel bacterial artificial chromosome (BAC) trans-
genicmouse that reports transcriptional activity of the Il7r gene
locus. We show that Gfi1 is a transcriptional repressor of the
Il7r gene locus, but only in CD8 lineage cells, by assessing Il7r
reporter activity in Gfi1-deficient and Gfi1-transgenic thymo-
cytes and T cells. Our observations place Gfi1 as a lineage-
specific and developmental stage-dependent transcriptional
repressor of IL-7R in vivo.
EXPERIMENTAL PROCEDURES
Animals—C57BL/6 and RAG2-deficient mice were obtained
from The Jackson Laboratory (Bar Harbor, ME). Gfi1-deficient
(Gfi1KO) and Gfi1-transgenic (Gfi1Tg) mice have been previ-
ously described (24, 25). Animal experiments were approved by
the National Cancer Institute Animal Care and Use Commit-
tee, and all mice were cared for in accordance with National
Institutes of Health (NIH) guidelines.
Generation of 7RIG-BACTg Transgenic Mice—A BAC clone
(RP23-365P6) containing the Il7r gene locus was modified by
recombineering an IRES-EGFP cassette into the 3UTR region
of the gene in Escherichia coli (26). Briefly, a targeting vector
was generated containing (1) an HincII fragment of the
pIRES2EGFP plasmid (Clontech) (2), an SV40 late poly(A) sig-
nal sequence PCR amplified from the pGL3Basic plasmid (Pro-
mega), (3) aKpnI fragment of the pLTM260plasmid containing
an Frt and a loxP-flankedNeomycin resistance genewith a PGK
promoter and a bGHpoly(A) signal and (4) two flanking regions
(210 and 300 bp long) homologous to the Il7r 3 UTR PCR
amplified from BAC DNA. This reporter BAC DNA was puri-
fied by sucrose gradient centrifugation and was injected into
fertilized B6 oocytes to generate transgenic mice as described
(27). Foundermicewere identified by flow cytometric detection
of GFP expression on peripheral blood lymphocytes. One
transgenic line out of 4 founders that recapitulated IL-7R
expression patterns on peripheral T and B lymphocytes was
selected for further study and named for this study “7RIG-
BACTg.” Note that this transgene is unique compared with a
recently reported BAC transgene, as we utilized an internal
ribosome entry site (IRES) element in the 3UTR to ensureGFP
reporter expression coincident with transgenic IL-7R expres-
sion (28). The transgenewas introduced into aGfi1Tg orGfi1KO
background by breeding.
Genotyping of IL-7R KO Allele by Quantitative Real
Time-PCR—Originally, the IL-7R-deficient (IL-7RKO)
mousewas generated by inserting a 1-kbMC1neo cassette into a
HindIII site within the third exon of the Il7r gene, around posi-
tion 90 of the 180-amino acid long extracellular domain (1).
The originally inserted neor gene is a modified neor gene from
pMC1Neo as described in Thomas and Capecchi (29). In this
altered neomycin resistance gene, a synthetic translation initi-
ation sequence “5-gccaatatgggatcggcc-3” is introduced. We
used the reverse sequence of this synthetic translation initi-
ation sequence in combination with an Il7r exon3-specific
primer to amplify a short PCR fragment. The exon 3-specific
primer corresponds to the amino acid sequence “GSSNICV”
of the IL-7R extracellular domain. Copy numbers of the
IL-7R KO allele was determined by real time-PCR using
primers IL7Rex3GSSNICV and MC1neo-R.
Cell Culture and Flow Cytometric Analysis—Thymocytes or
LN cells were prepared by processing thymus and LN into sin-
gle cell suspensions and filtering through a 0.70-m cell
strainer (BD Biosciences). For cell culture or stimulation, pro-
cessed cells were incubated at 5  106 cells/ml in 7.5% CO2 at
37 ºC in RPMI 1640 medium supplemented with 10% fetal calf
serum, 100 units/ml of penicillin/streptomycin, 2 mM L-glu-
tamine, 1 minimal essential medium vitamins/nonessential
amino acids, and 50 M -mercaptoethanol. For dexametha-
sone treatment, cells were incubated with 10 M water-soluble
dexamethasone (catalog number D4902, Sigma) for 18 h in the
presence or absence of 10 M mifepristone (RU486; catalog
number M8046, Sigma). For flow cytometry, one million
3B4.15 hybridoma, thymocytes, or lymph node cells were used
per staining with the corresponding antibodies and incubated
for 45 min on ice. After washing with FACS buffer (1 HBSS,
0.5% sodium azide, 0.5% BSA), cells were analyzed on LSRII,
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ARIAII, FACSCanto, or FACSCalibur flow cytometers (BD
Biosciences). Dead cells were excluded by forward light scatter
gating and propidium iodide or 7-Aminoactinomycin D stain-
ing. Antibodies with the following specificities were used for
staining: Qa-2 (clone 69H1-9-9), CD44 (clone IM7), HSA
(clone M1/69), IL-7R (clone A7R34), IL-2R (clone PC61.5),
IL-21R (clone ebio4A9), CD8 (clone 53-6.7); all from eBiosci-
ence); c-chain (clone 4G3), IL-4R (clone mIL4R-M1), CD4
(clone GK1.5), TCR (clone H57–957), and B220 (RA3–6B2)
(all fromBDBiosciences); and IL-2R (clone 5H4) fromBioleg-
end. Data were analyzedwith software designed by theDivision
of Computer Research and Technology at the NCI or with
FlowJo 9.4.3 software (Treestar).
Adoptive Transfer—Purified LNT cells from 7RIG-BACTg
andGfiTg7RIG-BACTgmicewere labeledwith CellTrace Violet
(Invitrogen) and adoptively transferred into RAG2-deficient
host mice. 4  106-Labeled cells were intravenously injected,
and spleen and lymphnode cells fromhostmicewere harvested
5 days later. Single cell suspensions were stained for surface
IL-7R and TCR expression and analyzed by flow cytometry.
RNA Isolation and Northern Blot Analysis—Total RNA was
isolated using TRIzol (Invitrogen). Equal amounts of RNAwere
resolved in a 1.5% agarose gel under denaturing conditions and
blotted onto Hybond-N nylon membranes (Amersham Bio-
sciences). Radioactive probes for detecting specific gene
expression were generated using the EZ-strip DNA kit
(Ambion) and used to hybridize with RNA-blotted membrane
inUltraHyb hybridization solution (Ambion) at 42 °C. The next
day, membranes were washed two times with 2 SSC, 0.1%
SDS for 30min and twomore times with 0.1 SSC, 0.1% SDS at
55 °C. Membranes were exposed to a PhosphorImager screen
(Amersham Biosciences) and analyzed.
Expression Plasmids and Gene Transfer—Full-length and
truncation mutants of murine Gfi1 cDNAs were C-terminal
FLAG epitope-tagged and cloned into the pBluescript II plas-
mid using oligonucleotides incorporating 5 XhoI and 3 NotI
restriction sites. All cDNAs were transferred from pBluescript
II to a retroviral expression plasmid, LZRSpBMN-linker-IRES-
EGFP, using XhoI and NotI restriction enzymes. This resulted
in bicistronic expression of FLAG epitope-tagged Gfi1 cDNA
variants with an EGFP reporter gene. The following oligonu-
cleotide pairs were used to amplify Gfi1 truncations: D-ZF,
M13dZFsrev; mGfi1-ZF, ZFsforT7; and D-SNAG,
dSNAGforT7. LZRSpBMN-linker-IRES-EGFP with full-
length or truncatedGfi1 cDNAswere transfected into Phoenix-
Eco retroviral packaging cell lines with a plasmid encoding eco-
tropic retrovirus envelope proteins (pCL-EcoAddgene plasmid
12371) (30) and supernatants were collected for 2 days, pooled,
and filtered through 45-mfilters. 3B4.15 cells were infected by
spin infection in the presence of 6 g/ml of Polybrene (Sigma).
Oligonucleotides Used in this Study—The following oligonu-
cleotides were used to PCR amplify Gfi1 cDNA constructs.
Restriction enzyme sites (XhoI and NotI) used for cloning are
shown in bold lettering, FLAG epitope tag sequence is shown in
italics, and the start and stop codons are underlined; M13,
5-CGCCAGGGTTTTCCCAGTCACGAC-3; T7, 5-TAA
TAC GAC TCA CTA TAG GG-3; dSNAGfor, 5-ATC TCG
AGGCCACCATGCCAGGGCCGGACTACTCC-3; ZFs-
for, 5-ATC TCGAGG CCA CCA TGT CCT ACA AAT GCA
TCA AAT G-3; dZFsrev, 5-ATG CGG CCG CTA TTT ATC
GTC ATC GTC TTT GTA GTC CAT GGA TCC TTT GTA
GGA GCC GCC G-3; dSNAGrev, 5-ATG CGG CCG CTA
TTT ATC GTC ATC GTC TTT GTA GTC CAT GGA TCC
AGA ACG CGG CTG GTG ATA G-3; IL7Rex3GSSNICV,
5-GGT AGC AGC AAT ATA TGT GTG-3; MC1neo-R,
5-GGC CGA TCC CAT ATT GGC-3.
Microarray Analysis—Expression analysis was performed on
3B4.15T hybridoma cells, either untreated or treatedwith 1M
dexamethasone (Sigma) for 16 h. Total RNA was extracted
using TriReagent (Sigma), RNA quality was confirmed on an
RNA 6000 Nano chip (AGT-5067-1511) in an Agilent Bioana-
lyzer. Double-stranded cDNA was generated using a Super-
Script cDNA Synthesis Kit (Invitrogen), and the cDNA was
then labeled with Cy-3, cleaned, quantified, and hybridized
according to themanufacturer’s protocols (Roche-Nimblegen).
Nimblegen full genome Mouse Expression arrays (12X135K
RO5543797) were washed and scanned at the Sabanci University
Nanotechnology Research and Application Center-SUNUM.
Results were processed using the ANAIS software (31). Array
quality was assessed at the probe level. Values for 3 probes for
each gene in each array were combined to summarize gene
expression from probe sets. RobustMulti-Array Analysis back-
ground normalization and quantile normalization were per-
formed for intra- and inter-array normalization, respectively.
Genes with signal intensities above a 95% random threshold
were chosen for further studies. Differentially expressed genes
were obtained based on the following criteria: fold-change2.5
and analysis of variance p value 0.01. Hierarchical clustering
was applied to the top 500 differentially expressed genes with
Genesis software (32). The data discussed in this publication
have been deposited in NCBI’s Gene Expression Omnibus (33)
and are accessible through GEO Series accession number
GSE39296.
RESULTS
Glucocorticoids Induce IL-7R Expression by Down-regulat-
ing Expression of Gfi1—Treatment of primary T lymphocytes
and T cell lines with glucocorticoids, such as Dex, results in the
up-regulation of surface IL-7R expression (17, 34). T cells nor-
mally express high levels of surface IL-7R but the I-Ek-re-
stricted, PCC-specific T cell hybridoma 3B4.15 expresses only
low levels of IL-7R (23). Nevertheless, when treated with glu-
cocorticoids such as Dex, 3B4.15 cells dramatically up-regulate
both IL-7RmRNA and cell surface protein expression (Fig. 1,
A and B). These results parallel those previously obtained using
the transformedmurine T cell line KKF, which responds toDex
by up-regulating IL-7R protein expression (16). Dex treat-
ment induces nuclear localization and binding of the glucocor-
ticoid receptor transcription factor to an evolutionarily con-
served region 3.5 kb upstream of the transcriptional start site of
the Il7r gene (16). Thus, Dex-induced IL-7R up-regulation has
been considered to be a direct transcriptional effect of activated
GRs. To understand other gene regulators that control this
phenotypic change, we compared the gene expression profiles
of mock treated versus Dex-treated 3B4.15 cells by high cover-
age Nimblegen expression arrays with 135,000 features.
Gfi1 Controls IL-7R Transcription
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Microarray results confirmed that Dex-treated 3B4.15 T
hybridoma cells indeed up-regulated IL-7R gene expression
(supplemental Fig. S1).
To confirm the specificity of Dex signaling in 3B4.15
hybridomas, first, we examined the expression profiles of the
known Dex-regulated genes, GILZ (Tsc22d3) and GITR
(Tnfrsf18) and found that these genes were positioned in the
top 520 differentially expressed genes (supplemental Fig. S1)
(35–37). Next, we further analyzed the expression profiles of all
transcription factors that have previously been reported to reg-
ulate Il7r transcription. Among these were: glucocorticoid
receptor, Gfi1, its close homologGfi1b,GABP and its partners
GABP1 and GABP2, PU.1 (Sfpi1), Runx1/3, NF-B,
FoxOA1/3, FoxP1, and FoxP3. Notably, we found that among
these transcription factors, Gfi1 was the only one that passed
our differentially expressed gene criteria of fold-change  2.5
and analysis of variance p value  0.01. Thus, Dex treatment
results in an up-regulation of Il7r transcription and a dramatic
down-regulation of the zinc finger repressor protein Gfi1
mRNA expression (Fig. 1B and supplemental Fig. S1).
Gfi1 was previously proposed to repress IL-7R transcrip-
tion during lymphocyte development (14). Consequently, we
wished to assess whether Gfi1 down-regulation would contrib-
ute to IL-7R up-regulation in 3B4.15 cells. To test this idea, we
retrovirally overexpressed Gfi1 in 3B4.15 cells. Strikingly, Gfi1
overexpression inhibited IL-7R up-regulation by dexametha-
sone, and Gfi1 overexpressing 3B4.15 cells remained IL-7R
low (Fig. 1C). Thus, Dex induces the down-regulation of endog-
enous Gfi1 expression, but retroviral overexpression of Gfi1 is
maintained even in the presence of Dex, and results in these
cells remaining IL-7R low. This effect was indeed directly
dependent on GR, because Dex treatment in the presence of
RU-486, which is a competitive inhibitor ofDex forGRbinding,
completely inhibited IL-7R up-regulation (Fig. 1D).
Next, to understand the mechanism of Gfi1-mediated
repression of IL-7R expression, we retrovirally overexpressed
a series of truncated Gfi1 cDNAs and assessed their effects on
the Dex response of 3B4.15 cells (supplemental Fig. S2, A and
B). Although expression of full-length Gfi1 significantly sup-
pressed IL-7R re-expression, truncated Gfi1 lacking the dem-
ethylase-recruiting Snail-Gfi (SNAG) domain or the DNA
binding zinc finger (ZF) domain failed to do so (Fig. 1E). Thus,
repression of IL-7R expression by Gfi1 requires both its tran-
scriptional repressor and the DNA binding domains and
uncover Gfi1 to be a potent transcriptional inhibitor of IL-7R
expression that acts downstreamofDex signaling, which de-re-
presses Il7r transcription.
Assessing IL-7R Transcription in Vivo Using a Novel IL-7R
Reporter Mouse—Untreated 3B4.15 cells express high levels of
Gfi1 and low levels of IL-7R. Mature resting T cells, on the
other hand, express only low levels of Gfi1 and high levels of
IL-7R (38). Therefore, Gfi1 levels in T cells in vivo do not
correspond to those in 3B4.15 T hybridomas. To test whether
Gfi1 can also control IL-7R expression in vivo, we generated a
novel IL-7R transcriptional reporter transgenic mouse. We
used a 210-kb BAC fragment containing the Il7r gene locus and
inserted an IRES-EGFP cassette in the 3 untranslated region
(UTR) of the Il7r gene. We used this construct in pronuclear
injections to generate transgenic mice (7RIG-BACTg) (supple-
mental Fig. S3).
Because the BAC construct contained the full Il7r gene locus,
including putative transcriptional control regions, we expected
the transgenic Il7r gene to faithfully reproduce expression of
endogenous Il7r. To test this, we assessed IL-7R surface levels
on freshly isolated 7RIG-BACTg thymocytes. Endogenous
IL-7R displays a characteristic on-off-on pattern during the
progression through the DN-DP-SP stages of thymocyte devel-
opment (3, 39). Indeed, 7RIG-BACTg thymocytes showed the
expected on-off-on pattern for IL-7R expression in the thy-
mus. These data suggest that transgenic IL-7R transcription is
appropriately controlled in 7RIG-BACTg thymocytes (Fig. 2A).
Notably, IL-7R expression by 7RIG-BACTg differed from that
of a human CD2 promoter/enhancer-driven IL-7R transgene
(IL-7RTg), in its ability to down-regulate IL-7R expression on
FIGURE 1. Glucocorticoids up-regulate IL-7R expression while down-
regulating Gfi1. A, Dex induces surface IL-7R expression on 3B4.15
hybridoma. Single parameter histograms of IL-7R expression on 3B4.15
hybridomacells incubatedovernight inmediumorwithDex. Isotype staining
controls are shown in dotted line. B, Dex-induced IL-7R expression inversely
correlateswithGfi1 expression. Northernblot analysis of total RNA fromover-
nightmediumorDex-treated 3B4.15 cellswith probes indicated on the left.C,
Gfi1 overexpression inhibits Dex-induced IL-7R expression. Histograms
show surface IL-7R expression on control retrovirus-infected 3B4.15 cells
incubated for 16 h, either in medium (filled histogram) or with Dex (dotted
line). Solid histogram shows IL-7R expression on Dex-treated, Gfi1-express-
ing retrovirus-infected 3B4.15 cells. D, Dex-induced IL-7R expression is a
glucocorticoid receptor dependent event. Histograms show IL-7R expres-
sion on 3B4.15 cells incubated for 16 h in medium (filled histogram), with
dexamethasone (solid histogram), orwithDex in thepresenceofMifepristone
(RU486) (dotted line). E, zinc finger and SNAG domains of Gfi1 are required for
inhibiting Dex-induced IL-7R expression. IL-7R surface expression on
3B4.15 cells was quantified into linear fluorescence units, with IL-7R expres-
sion on empty LZRS retrovirus-infected cells set equal to 100. Inhibition of
IL-7R expression by retroviruses expressing either full-length (mGfi1), or
domain deletions of Gfi1 were compared. Zinc finger domain deleted (-ZF),
N-terminal truncation containing only the ZF domain (mGfi1-ZF), and SNAG
domain deleted (-SNAG).
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DP thymocytes (Fig. 2A). These results support the expectation
that the BAC transgene retained all endogenous regulatory ele-
ments for correct IL-7R expression. Notably, IL-7R surface
levels on 7RIG-BACTg transgenic cells were significantly higher
compared with WT controls, presumably because Il7r gene
transcription was active both from the endogenous and the
transgenic Il7r locus. To demonstrate that the 7RIG-BACTg
transgene faithfully reports Il7r gene transcription, we assessed
GFP expression in thymocytes. GFP expression also followed
the on-off-on pattern of IL-7R expression in DN, DP, and SP
thymocytes, respectively, indicating that transcription from the
transgenic locus was correctly inhibited in DP thymocytes (Fig.
2B). We also assessed IL-7R reporter expression in peripheral
LN cells.Mature B cells do not express IL-7R. Accordingly, we
found that 7RIG-BACTgDN lymphnode cells, which include all
mature B cells, were negative for GFP expression (Fig. 2C). CD4
and CD8 lymph node T cells, on the other hand, correctly
expressed high levels of GFP. Interestingly, CD8 T cells
reported higher levels of Il7r transcription than CD4 T cells
based on their GFP levels (Fig. 2C). These data confirm that
7RIG-BACTg reporter mice faithfully represent endogenous
IL-7R expression in vivo and reveal a hitherto unappreciated
difference in IL-7R transcription levels in CD4 and CD8 T
cells.
Cytokine-induced Regulation of 7RIG-BACTg Expression—
To further document distinct IL-7R expression in CD4 and
CD8 T cells, we quantified surface IL-7R and intracellular
GFP levels in freshly isolated 7RIG-BACTg LN T cells. We con-
firmed statistically significant higher levels of both IL-7R
expression and transcription in CD8 T cells in multiple exper-
iments (Fig. 3, A and B). Moreover, such lineage-specific
IL-7R expression was developmentally set as CD4 and CD8 T
cells incubated overnight in medium in the absence of in vivo
signals still displayed distinct levels of IL-7R expression (data
not shown).
The Il7r gene locus is exquisitely sensitive to cytokine signal-
ing. For instance, in vivo IL-7 signaling down-regulates Il7r
transcription and steady-state levels of IL-7RmRNA inT cells
(13). To determine whether the transgenic IL-7R gene locus
also responds to cytokine treatment, we incubated LN T cells
from either WT or 7RIG-BACTg mice overnight in medium or
in the presence of IL-7. The next day, total RNA was extracted
and IL-7R mRNA signals were assessed and compared with
those from freshly isolated T cells. In both WT and 7RIG-
BACTg T cells, overnight release from the cytokine-rich in vivo
environment highly up-regulated IL-7R mRNA expression
(Fig. 3C). Furthermore, overnight IL-7 signaling potently sup-
pressed IL-7RmRNA expression in both WT and transgenic
T cells. These results suggest that both the endogenous and the
transgenic Il7r loci are regulated in a cytokine-dependentman-
ner. More importantly, GFP mRNA levels also faithfully repli-
cated IL-7R expression, which confirms the validity of this
transgenic model as an in vivo IL-7R reporter (Fig. 3).
Restoring T Cell Development in IL-7R-deficient Mice by
7RIG-BACTg—IL-7R deficiency results in severely impaired T
cell development and peripheral T cell homeostasis. Because
7RIG-BACTg replicates expression of endogenous Il7r, we
wished to know if the BAC transgene could restore T cell
FIGURE 2. 7RIG-BACTg faithfully reports IL-7R expression in vivo. A, cell surface IL-7R expression during thymocyte development. IL-7R expression on
gated thymocyte subpopulations fromWTmice (upperpanel), 7RIG-BACTg (lowerpanel), andahumanCD2mini-cassettedriven IL-7RTgmice (middlepanel) are
shown (solid line) over isotype control staining (dotted line). B, assessing IL-7R transcription using GFP reporter activity in thymocyte subpopulations. Total
thymocytes fromWT and 7RIG-BACTg mice were stained for CD4 and CD8 surfacemarkers, and GFP expression was determined in individual subpopulations.
Data are representative of four independent experiments.C, lineage specific IL-7R transcription in LNT cells. Total LN cells fromWTand7RIG-BACTgmicewere
stained for CD4 and CD8 surface markers, and GFP expression was determined in CD8 and CD4 LN T cells. Mean fluorescence intensity of surface IL-7R are
shown for CD8 and CD4 T cells, respectively. Data are representative of four independent experiments.
FIGURE 3. Transcriptional regulation of GFP reporter expression. A, relative surface IL-7R expression on CD4 and CD8 LNT cells. Surface IL-7R levels on
7RIG-BACTg T cells were quantified in mean fluorescence intensity and normalized to IL-7R levels on CD4 cells. Bar graph shows mean  S.E. from three
independent experiments. B, relative GFP expression in CD4 and CD8 LN T cells. Intracellular GFP levels in 7RIG-BACTg T cells were quantified in the mean
fluorescence intensity and normalized to GFP levels in CD4 cells. Bar graph showsmean S.E. from three independent experiments. C, purified LN T cells from
WTor 7RIG-BACTgmicewere assessed for IL-7R andGFPmRNA expression by Northern blot analysis with probes indicated on the left. Total RNAwas isolated
from fresh, overnight medium incubated, or overnight IL-7-treated LNT cells.
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defects in IL-7RKOmice. To test this, we crossed 7RIG-BACTg
into IL-7RKO mice to generate IL-7RKO7RIG-BACTg mice
(supplemental Fig. S4A). In these mice, thymic  T cell devel-
opment was largely restored as demonstrated by thymocyte
CD4 versus CD8 profiles and TCR surface expression (Fig.
4A). Also, thymic NKT cell development and  T cell genera-
tion was dramatically improved comparedwith IL-7RKOmice
(supplemental Fig. S4,B andC). Notably, total thymocyte num-
berswere also restored comparedwith IL-7RKOmice, but they
did not fully recover to WT levels (Fig. 4B). To further under-
stand this, we analyzed surface IL-7R levels on thymocytes,
and we found that IL-7RKO7RIG-BACTg mice expressed sig-
nificantly higher levels of IL-7R thanWTmice (Fig. 4C). This
is presumably caused by insertion ofmultiple copies of the BAC
transgene into the genome as usually observed in BAC trans-
genesis. Elevated levels of IL-7R, however, have been shown to
increase IL-7 consumption and competition for IL-7, which
results in an overall decrease in thymocyte numbers (40, 41).
Thus, decreased total thymocyte numbers might reflect quan-
titative differences in surface IL-7R expression between WT
FIGURE 4. 7RIG-BACTg restores thymocyte development and T cell homeostasis in IL-7RKO mice. A, thymocyte development in IL-7RKO7RIG-BACTg.
Total thymocytes from WT and IL-7RKO7RIG-BACTg mice were assessed for CD4, CD8, and TCR surface marker expression (top and middle). Mature TCRhi
thymocytes were analyzed for CD4 and CD8 profiles (bottom). B, total thymocyte numbers in IL-7RKO7RIG-BACTg mice. Thymocyte numbers from WT,
IL-7RKO7RIG-BACTg, and IL-7RKO mice were determined. Bar graph shows mean S.E. from three independent experiments. C, surface IL-7R on WT and
7RIG-BACTg thymocytes. IL-7R expression was determined on WT and IL-7RKO7RIG-BACTg thymocyte subpopulations. Bar graph shows mean S.E. from
three independent experiments. D, peripheral T cell homeostasis in IL-7RKO7RIG-BACTg mice. LN cells were isolated, counted, and phenotyped for CD4 and
CD8 expression (top). Bar graph shows total LN numbers (bottom). Data show mean S.E. from four independent experiments. E, surface IL-7R on WT and
7RIG-BACTg LNT cells. IL-7R expression was assessed and quantified on WT and IL-7RKO7RIG-BACTg LN cell subpopulations. Data show representative
histograms from three independent experiments.
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and IL-7RKO7RIG-BACTg thymocytes. Interestingly, how-
ever, no major differences were observed in peripheral LN T
cell numbers and CD4/CD8 profiles (Fig. 4D), despite surface
IL-7R levels on transgenic LN T cells being still higher than
WT counterparts (Fig. 4E). Thus, thymocytes and LN T cells
are differently affected by IL-7R levels, likely because of the
different mechanisms of proliferation and homeostasis in these
two organs. Collectively, we find that BAC transgenic IL-7R is
expressed and regulated in a developmentally correct fashion,
and consequently restores T cell development and mainte-
nance in IL-7R-deficient mice.
Gfi1 Overexpression Suppresses Il7r Gene Transcription in
CD8 T Cells—Using these reporter mice, next we asked
whetherGfi1 can suppress IL-7R transcription and expression
in vivo. To this end, we introduced the 7RIG-BACTg onto mice
expressing a T lineage-specific, human CD2 promoter driven
Gfi1 transgene (25) to generate Gfi1Tg7RIG-BACTg mice and
determined their IL-7R transcription by analyzing GFP
expression. Strikingly, in Gfi1Tg7RIG-BACTg thymocytes, we
found that GFP levels were significantly down-regulated by
Gfi1, but that this was specific and restricted to CD8SP thymo-
cytes (Fig. 5A). These results suggest that transgenic Gfi1
expression fails to suppress IL-7R transcription in any other
thymocyte subpopulation than in CD8SP cells. Such a specific
effect of Gfi1 on CD8 lineage cells was further confirmed in
peripheral CD8 T cells. We found both surface IL-7R and
intracellular GFP levels selectively down-regulated in CD8, but
not in CD4 T cells (Fig. 5B). Thus, these data document that
Gfi1 only down-regulates IL-7R gene transcription and sur-
face protein expression in CD8 T lymphocytes, and that all
other thymocyte subpopulations and CD4 T cells are not sus-
ceptible to repression of this gene by Gfi1.
To further assess the specificity of Gfi1 transcriptional
repression, we examined expression of othermembers of thec
cytokine receptor family. Thec cytokine family is composed of
IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 (42), and antibodies are
available for surface staining of eachmember of the c receptor
family with the exception of IL-9. Consequently, we examined
expression of c cytokine receptors for IL-2R, -2R, c,
IL-4R, IL-7R, and IL-21R on WT and Gfi1Tg CD8 T cells
(Fig. 5C). Strikingly, IL-7Rwas the only cytokine receptor that
was significantly affected by Gfi1 overexpression (Fig. 5D),
which revealed a highly selective effect of Gfi1 on IL-7R and
reaffirmed its specificity for CD8 T cells.
Gfi1 Deficiency Up-regulates Il7r Transcription in CD8 T
Cells—Such a CD8 lineage-specific effect of Gfi1 was intrigu-
ing.Onepotential explanation could be thatGfi1 is expressed in
all thymocytes and T cells, but that its repressor activity is only
limited toCD8Tcells. Consequently, wewished to testwhether
removal of Gfi1 would up-regulate IL-7R expression in T cells
other than in CD8 lineage cells. To this end, we generated
Gfi1KO7RIG-BACTg mice and analyzed the GFP levels in thy-
mocytes andmature LNT cells (supplemental Fig. S5A and Fig.
6A) (24). Notably, Gfi1 deficiency failed to de-repress IL-7R
transcription inmost thymocytes, with the exception of CD8SP
thymocytes (supplemental Fig. S5A). DP thymocytes, which
express high levels of Gfi1 and are completely silent for IL-7R
transcription, were still negative for GFP expression, whenGfi1
expression was ablated. These results indicate that Gfi1 is not
required to suppress IL-7R expression in this particular sub-
set. Rather, the effect of Gfi1 was highly restricted to post-se-
lection CD8 lineage cells as GFP expression was quantitatively
increased in both CD8SP thymocytes and LN CD8 T cells only
(supplemental Fig. S5A and Fig. 6B).
Because absent Gfi1 was sufficient to up-regulate IL-7R
expression on CD8 T cells, next, we wished to know whether
this would correlate with the Dex effect that we observed in
3B4.15 cells (Fig. 1, A and B). To this end, we stimulated WT
and Gfi1Tg T cells with Dex and assessed their surface IL-7R
expression after overnight culture (Fig. 6C). Although WT
CD8 T cells significantly up-regulated IL-7R as previously
observed (17), IL-7R levels onGfi1KOCD8Tcells were unaf-
fected by stimulation with Dex (Fig. 6C). Notably, IL-7R
expression on Gfi1KO CD4 T cells was still up-regulated by
Dex indicating that Gfi1 effect is CD8 lineage specific (supple-
mental Fig. S5B). These data strongly suggest that a major role
for Dex is to suppress Gfi1, and that Gfi1 directly controls
IL-7R expression in CD8 T cells.
Gfi1 deficiency has been proposed to promote CD8memory
phenotype cell generation (43). Because memory CD8 T cells
express high levels of IL-7R (42), we wished to test whether
increased IL-7R is a consequence of memory cell differentia-
tion or a direct effect ofGfi1 deficiency.GFP levels inCD8Tcell
subsets demonstrated that IL-7R transcription was signifi-
cantly increased in both naive (CD44low) and activated/mem-
ory (CD44high) phenotype CD8 T cells (Fig. 6D). Thus, we con-
clude that absent Gfi1 expression de-represses IL-7R
transcription and expression in all CD8Tcells independently of
their differentiation status.
In Vivo Analysis of IL-7R Transcription Using 7RIG-BACTg
on a Single Cell Basis—We wished to know if using the 7RIG-
BACTg could provide us with new insights on IL-7R expres-
sion that so far has not been experimentally feasible to assess.
Adoptive transfer of CD8 T cells into chronic lymphopenic
mice results in lymphopenia-induced homeostatic prolifera-
tion (LIP). Slowly dividing homeostatic proliferation is depend-
ent on IL-7, whereas rapid proliferation is IL-7 independent
and driven by commensal antigens (44). To further understand
the role of IL-7 in this process, it would be important to assess
how IL-7R expression is regulated during LIP. To do so, we
assessed surface IL-7R and intracellular GFP expression on
day 5 adoptively transferred 7RIG-BACTg CD8 T cells. Analyz-
ing IL-7R transcription in adoptively transferred cells on a
single cell basis has not been possible so far. IL-7 signaling sup-
presses IL-7R expression under steady-state conditions (13).
Surprisingly, however, surface IL-7R levels remained largely
unchanged during IL-7-driven LIP as assessed on slowly divid-
ing cells (Fig. 7, A, left, and B). Strikingly, in the same cells, Il7r
transcription was dramatically down-regulated upon cell divi-
sion, as demonstrated by reduced GFP expression in cell trace-
diluted cells (Fig. 7, A, right, and B). These data indicate that
surface IL-7R expression is not a reliable marker for Il7r tran-
scription, at least during homeostatic proliferation. They fur-
ther suggest the operation of a transcription-independent
mechanism of surface IL-7R expression, which could be either
increased recycling of endocytosed IL-7R, stabilization of pre-
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existing IL-7R proteins or a yet unknown post-transcriptional
mechanism.We are currently in the process of addressing these
possibilities.
BecauseGfi1 suppresses Il7r transcription, nextwewished to
assess the effect of Gfi1 on IL-7R expression during LIP. Day 5
adoptively transferred Gfi1Tg7RIG-BACTg cells displayed a
comparable pattern of surface IL-7R and intracellular GFP
expression to WT cells, in that GFP levels steadily decreased
upon proliferation (Fig. 7C, right) but surface IL-7R levels
remain largely unaffected (Fig. 7C, left). Thus, the dichotomoy
of IL-7R transcription and surface protein expression during
LIP still remained distinct in Gfi1Tg7RIG-BACTg cells. More-
over, LIP further down-regulated IL-7R transcription in
Gfi1Tg cells, which is presumably mediated by a mechanism
independent of Gfi1. Importantly, Gfi1 overexpression signifi-
cantly impaired CD8 T cell LIP, which correlated with lower
FIGURE 5.Gfi1 suppresses IL-7R expression and transcription in vivo. A, suppression of GFP reporter activity by overexpression of Gfi1. IL-7R transcrip-
tional activities in individual thymocyte subpopulationsweredeterminedusing the7RIG-BACTgonWTorGfi1Tg backgrounds. Contourplots are representative
of four independent experimentswith 4WTand5Gfi1Tgmice transgenic for 7RIG-BACTg.Bar graph showsmeanS.E. four independent experiments.B, IL-7R
surface expression and transcription inGfi1Tg transgenic CD4 andCD8 LNT cells. The effect of Gfi1was assessed inWTorGfi1Tgmice transgenic for 7RIG-BACTg.
Cell surface IL-7R andGFP expressionwere determined by flow cytometry. Bar graph showsmean S.E. from three independent experimentswith 3WT and
5Gfi1Tg7RIG-BACTgmice.C,expressionofc cytokine receptor families onGfi1TgCD8 LNTcells. Surfaceexpressionof the indicatedc cytokine receptorswere
determined on gated CD8 T cells fromWT and Gfi1Tgmice. Data are representative of three independent experiments.D, Gfi1Tg specifically suppresses IL-7R
expression on CD8 T cells. Surface cytokine receptor levels on Gfi1Tg CD8 T cells were quantified and normalized to levels on WT CD8 T cells. Bar graph
shows mean S.E. of three independent experiments.
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FIGURE 6. Gfi1 deficiency de-represses IL-7R transcription and expression in CD8 lineage cells. A, increased GFP reporter activity in Gfi1KO7RIG-BACTg
CD8 T cells. GFP expression was assessed in CD8 and CD4 T cells fromWT or Gfi1KO mice expressing 7RIG-BACTg. Data are representative of four independent
experiments. B, quantification of GFP expression in Gfi1KO7RIG-BACTg T cells. Mean fluorescence intensity of intracellular GFP levels were determined from
7RIG-BACTg and Gfi1KO7RIG-BACTg LNT cells. Bar graph shows themean S.E. of two independent experiments. C,Dex effect on CD8 LNT IL-7R expression.
Surface IL-7R expression was determined onWT and Gfi1KO CD8 T cells incubated overnight inmedium or Dex.D, the effect of Gfi1 on IL-7R transcription is
independent of activation/differentiation status in CD8 T cells. GFP reporter expression was assessed in freshly isolated CD44lo and CD44hi CD8 T cells from
7RIG-BACTg and Gfi1KO7RIG-BACTg mice. Data are representative of four independent experiments.
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IL-7R levels on Gfi1Tg CD8 T cells (Fig. 5B). Thus, Gfi1 sup-
presses IL-7R expression and also IL-7-dependent prolifera-
tion. Taken together, these results uncover Gfi1 as a critical
regulator of IL-7R transcription and expression in vivo, but
exclusively in CD8 lineage thymocytes and T cells.
DISCUSSION
To understand themolecular mechanisms of IL-7R expres-
sion during T cell development and activation, here we gener-
ated a novel BACGFP-reporter transgene and utilized this tool
to assess IL-7R transcription in vivo. The BAC transgene was
constructed by inserting a GFP-reporter and an IRES element
into the 3 UTR of the murine Il7r gene. Consequently, BAC
reporter mice overexpressed full-length IL-7R proteins in
addition to GFP. We affirmed the developmentally correct
expression of reporter transgenes by assessing lymphocyte dif-
ferentiation in IL-7R-deficient mice reconstituted with the
BAC construct (IL-7RKO7RIG-BACTg). In these mice, devel-
opment of all IL-7R-dependent lymphoid cell populations,
including-, -T cells, B-cells, andNKT cells, were restored.
Thus, the transgenic Il7r gene locus in 7RIG-BACTg mice is
correctly and lineage specifically regulated, and it equipped us
with a new tool to assess IL-7R transcription and expression in
vivo.
IL-7R is the ligand-specific subunit of the functional IL-7
receptor, which is composed of the IL-7R chain and the
c-chain (4). In contrast to the c-chain, IL-7R expression is
dynamic and is actively regulated during T cell development
and differentiation. All developing thymocytes and allmatureT
cells express IL-7R, albeit at varying degrees. However, imma-
ture DP thymocytes are unique in that they have completely
terminated IL-7R expression. Such peculiar absence of
IL-7R on pre-selection DP cells was proposed to reflect a crit-
ical thymic selection mechanism that ensures a random but
self-MHC-specific TCR repertoire (39, 45, 46). Accordingly,
absent IL-7R expression renders DP thymocytes dependent
on selecting TCR signals and not on nondiscriminatory IL-7
signaling for survival.However, themolecularmechanisms that
terminate IL-7R expression in DP cells remain unclear. Along
this line, themolecular circuitry that re-induces IL-7R expres-
sion upon positive selection also remains unmapped. This is
even more intriguing as TCR signaling in mature T cells down-
regulates IL-7R expression, but in immature DP thymocytes,
TCR signaling induces IL-7R expression. Recent studies have
suggested that re-expression of IL-7R on DP cells is depend-
ent on positive selecting TCR signals in a NFAT- and MAPK-
dependent fashion and to a lesser degree on Akt (47). However,
the detailed mechanism and molecular events remain
unknown. Using 7RIG-BACTg mice, here we establish that
absent IL-7R expression in DP cells is a transcriptionally reg-
ulated event. Pre-selected DP cells failed to express GFP, while
positive selection and maturation resulted in re-expression of
GFP. With the 7RIG-BACTg reporter mouse, it is now feasible
FIGURE 7. In vivo effects of Gfi1 on IL-7R expression. A, IL-7R expression during lymphopenia-induced homeostatic proliferation. Surface IL-7R expres-
sion and intracellular GFP expression were assessed on day 5 adoptively transferred 7RIG-BACTg CD8 T cells in RAG-2-deficient host mice. Cell division was
monitored by CellTrace Violet dye dilution. Dot plots are representative of three independent experiments. B, IL-7R expression and transcription in prolifer-
ating donor cells. Mean fluorescence intensity of surface IL-7R (open circle) and intracellular GFP (closed circle) were assessed for each cell division (D1 toD6),
and normalized to nondividing cells (D1), which was set to 100 (%). Graph shows the mean S.E. from three independent experiments. C, IL-7R expression
on proliferating Gfi1Tg7RIG-BACTg CD8 T cells. Surface IL-7R expression and intracellular GFP expression was assessed on day 5 adoptively transferred
Gfi1Tg7RIG-BACTg CD8 T cells in RAG-2-deficient host mice. Cell division wasmonitored by CellTrace Violet dye dilution. Dot plots are representative of three
independent experiments. D, Gfi1 impairs lymphopenia-induced homeostatic proliferation. CellTrace Violet dilutions on slow dividing donor 7RIG-BACTg or
Gfi1Tg7RIG-BACTg were quantitated. Numbers indicate the percentage of cells that have undergone one or more divisions during homeostatic proliferation.
Data are representative of three independent experiments.
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to test nuclear factors that regulate IL-7R transcription in
vivo. We anticipate further applications of these reporter mice
in dissecting the thymic signals that lead to termination as well
as re-induction of Il7r transcription under various in vitro and
in vivo settings.
In this regard, we were able to assess the effect of a transcrip-
tional repressor on Il7r gene expression in vivo. Gfi1 has been
considered as a potential Il7r regulator in immature thymo-
cytes because of its high level of expression in pre-selection DP
thymocytes and its potent suppression of IL-7R in pre-B cells.
As such, Gfi1KO7RIG-BACTg mice offered a unique opportu-
nity to assess the effect of Gfi1 on IL-7R transcription in DP
thymocytes in vivo. The complete absence of GFP signals in
Gfi1KO7RIG-BACTg DP thymocytes strongly suggested that
transcriptional silencing of Il7r gene expression does not
require Gfi1, at least in pre-selectionDP thymocytes. Inmature
T cells, Gfi1 clearly plays a more critical role. In fact, Gfi1 was
first reported to suppress IL-7R expression by analyzing
peripheral mature T cells (13). Nevertheless, a definitive and
direct role of Gfi1 in IL-7R transcription has remained highly
controversial. In some cases, surface IL-7R expression on
Gfi1KO T cells was found to be not, or insignificantly different
(38), and also increased IL-7R levels in Gfi1KO mice had been
suggested to be indirect, i.e. due to high proportions ofmemory
cells under Gfi1 deficiency (43). Moreover, increased Gfi1
mRNA levels in human IL-7Rhigh effector memory CD8 T
cells contradicted a repressor role forGfi1 in IL-7R expression
(48). Our current data showing significantly increased GFP
expression in GfiKO CD8 T cells, however, clearly documents
Gfi1 as an in vivo repressor for IL-7R transcription.
Nevertheless, contradictory observations still keep open the
possibility of a more complex regulatory network, with several
Gfi1 co-factors being involved. As such, the cis-elements par-
ticipating in the Gfi1 control of Il7r gene transcription are still
not well defined. In B lymphocytes, Gfi1 can bind to the second
intron of the Il7r gene to suppress transcription (14). Inmyeloid
cells, Gfi1 can also associatewith PU.1, an ETS family transcrip-
tion factor that binds to the promoter of IL-7R and activates
its transcription (49). However, PU.1 is not expressed in T lym-
phocytes. Rather another ETS family transcription factor,
GABP, is thought to occupy the ETS site in the promoter of the
Il7r gene (50). Whether Gfi1 can interact with the GABP pro-
tein is not known. But in T cells, GABP and Gfi1 were shown to
have opposing roles so that a direct interaction and mutual
suppression cannot be excluded (51). Thus, in addition to its
role in binding the Il7r gene promoter, GABPmay control Gfi1
expression asGABP-deficient splenocytes lackGfi1 expression,
presumably due to the positively acting GABP binding sites in
the Gfi1 promoter (52).
With Gfi1 emerging as a key control factor in IL-7R expres-
sion and also in many aspects of T and B cell immunology, it is
critical to know what controls Gfi1 expression. So far, an auto-
regulatory role for Gfi1 as well as a transregulatory role for
Gfi1b has been documented (53). Also, downstream signaling
of the GTPase Cdc42 has been proposed to suppress Gfi1
expression in resting T cells (54). The current study now pro-
poses that glucocorticoids are a new family of molecules that
can control Gfi1 expression. Glucocorticoids have been known
to take part in thymocyte development and selection (55–58).
Recently, conditional deletion of GR in pre-selection thymo-
cytes documented significantly reduced thymus cellularity with
an alteredTCR repertoire and increased negative selection (59).
Mechanistically, glucocorticoids have been shown to intersect
with TCR signaling and increase TCR signaling thresholds to
promote thymic selection (60). Our current data now also pro-
poses a role for Gfi1 downstream of GR signaling, and it would
be informative to assess the contribution of Gfi1 to the GR-de-
ficient phenotype.
In peripheral T cells, glucocorticoids are immunosuppres-
sive, but they also up-regulate IL-7R transcription and expres-
sion. The identification of Gfi1 as a novel target of Dex sheds
new light onto pre-existing observations on the effects of glu-
cocorticoids and in this regard, the discovery ofGfi1 as an inter-
mediary of Dex in IL-7R expression suggests that other Dex-
induced eventsmight also employ such amechanism.Although
the up-regulation of IL-7R expression in Dex-treated B cells,
which normally do not express IL-7R, could be another case of
an Gfi1-mediated Dex effect (34), inhibition of cytokine pro-
duction in Dex-treated cells also could be explained along this
line. Further studies are planned to address these possibilities
and to delineate a direct Dex effect versus Gfi1-mediated Dex
effects.
Although Gfi1 expression is down-regulated by Dex signal-
ing, and overexpression of Gfi1 can overcome Dex-mediated
up-regulation of IL-7R, we found, as expected, that GR is crit-
ical for Dex-mediated IL-7R up-regulation. GR binds to a
putative Il7r enhancer in an evolutionarily conserved sequence
3.5 kb upstream of the transcriptional start site (16). The GR
site in this evolutionarily conserved sequence is 50 base pairs
away from a FoxO1 transcription factor binding site, which
positively regulates gene expression in both naive CD4 and
CD8 T cells (20, 21). Whether this enhancer, the PU.1/GABP
binding promoter, and the putative Gfi1-binding intronic
silencer are the only functional control elements in the Il7r gene
locus is not known. In fact, a series of nuclear factors are known
to regulate IL-7R expression. In addition to Gfi1, two other
transcriptional repressors have been identified that down-reg-
ulate Il7r gene expression in T cells. The forkhead family tran-
scription factor FoxP1 suppresses IL-7R expression by com-
peting with the Il7r transactivator FoxO1 for enhancer
occupancy (19). On the other hand, FoxP3, which is specifically
expressed in regulatory T cells, directly suppress IL-7R
expression (22). Overexpression of a Gfi1 family member,
Gfi1b, can also repress IL-7R expression in T lymphocytes,
but presumably this effect is through the same intronic Gfi1
binding site, because the DNA binding domains of these two
factors are very similar (61). Notably, in our expression profil-
ing experiments, Gfi1 was the only nuclear factor that showed a
significant difference in expression upon Dex treatment.
Collectively, the present study identified and tested a novel
Il7r transcriptional control mechanism in vivo using a newly
established IL-7R reporter mouse. We validated these
reporter mice by complementing IL-7R deficiency, and we
utilized this tool to assess Il7r transcription downstream of
Gfi1. Using a lymphopenia-induced homeostatic proliferation
model, we further documented the superiority of these reporter
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mice in assessing IL-7R gene transcription in T cells to tradi-
tional methods. Finally, the current study not only resolves the
controversies surrounding the role of Gfi1 as a transcriptional
repressor of IL-7R in CD8 T cells but also demonstrates that
IL-7R expression in any other T cell population is indepen-
dent of Gfi1. The molecular basis for such lineage-specific reg-
ulation of cytokine receptor expression is intriguing and impor-
tant, and we think that our findings will provide a new venue to
identify critical players for controlling IL-7R expression.
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